Power-One predicts European solar revival in Q2
Signs of a resurgence in its European market prompted Power-One to project better-than-expected second-quarter profits on May 3 even as it said that first-quarter income dropped 84.1 percent to $4.9 million, or 3 cents per diluted share. Net sales were up 8.3 percent to $225.8 million. The company’s renewable energy division contributed $149 million to Read More →
ValueClick shares drop 22% on Q2 outlook
Shares of online advertising firm ValueClick plunged 22.2 percent after the Westlake Village-based firm projected lower-than-expected second-quarter revenues of between $155 million and $160 million. One analyst told Bloomberg News that the company is reducing traffic in its owned-and-operated website segment. ValueClick reported first-quarter profits of $21.6 million – 27.8 percent above the same quarter Read More →
Deckers stock slips as profits drop 59%
Unseasonably warm weather dampened first-quarter profits at Ugg boot maker Deckers Outdoor Corp and sent its share price tumbling more than 18 percent after the earnings announcement. The Goleta-based footwear company reported April 26 that quarterly profits were down 59 percent to $7.9 million, or 20 cents per share. The earnings drop came even as Read More →
FCAL profits drop 83%
First California Financial Group’s first-quarter profits plummeted 83.3 percent to $2.6 million, it reported on April 26. Per share, earnings were 8 cents, compared to 54 cents in the same quarter a year earlier. The Westlake Village-based parent of First California Bank said last year’s first-quarter results included a one-time $34.7 million pre-tax gain related Read More →
Ryland trims first-quarter loss as home sales pop
National homebuilder Ryland Group narrowed its first-quarter loss to $3 million from $17.4 milllion as orders for new homes jumped 46.6 percent. Ryland’s revenue climbed 28.7 percent year-over-year to $215.9 million as home orders and closings rose in tandem with average closing prices. The company, which last year moved its headquarters to Westlake Village, said Read More →
Amgen to buy Turkish firm in $700M deal
Thousand Oaks-based Amgen said it will acquire Mustafa Nevzat Pharmaceuticals, a major supplier of pharmaceuticals and injectable medicines in Turkey, in a deal that values the Turkish firm at $700 million. Amgen said that its focus on Turkey and the surrounding region is part of a broad international expansion strategy for the company. Amgen established Read More →
